This digital document is an article from National Right to Life News, published by National Right to Life Committee, Inc. on December 1, 2004. The length of the article is 687 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
We are standing at the threshold of a new and exciting medical era-an era of regeneration, rejuvenation, and renewal in which stems cells will set the stage for healing and in some cases, the restoration of injured, diseased, and debilitated tissues and organ. While stem cell therapy is still in its infancy, the field is rich with promise. The debate over the use of embryonic stem cells and the questionable effectiveness of adult stem cells have led many scientists and clinicians to concentrate
In August of 2006 I was struck by a truck while I was on a bicycle. My levels of injuries are L1 & L2 and a slight fractured T8. Consequently I am a complete paraplegic without movement and sensation from the waist down. In 2008 I had umbilical cord stem cells treatments. Within four months of inserting the umbilical cord stem cells into my spinal cord and with regular active assisted exercises, I started to move my legs for the first time since my accident. These cord stem cells come from a healthy baby and mother whereas it does not harm anybody. The treatment was done in Central America in a modern up-to date hospital. The treatments are ongoing, as I need to go back to get more in order to continue improving and regain my bladder and bowel functions. Video Rating: 5 / 5
Transplanting cells from healthy adult livers may help treat genetic liver-lung disorder
Transplanting cells from healthy adult livers may work in treating a genetic liver-lung disorder that affects millions of people worldwide, according to an animal study in the April 18 online edition of the Journal of Clinical Investigation. Read more on News-Medical-Net
Captain Boyd Melson returns May 19!
New York, NY (April 21, 2011) – US Army Captain and multi-time amateur champion Boyd “Rainmaker” Melson will return to the ring against an opponent to be named in a four round junior middleweight bout Thursday, May 19 at the Roseland Ballroom in his hometown of New York, NY. Read more on Hot Boxing News
Cord Blood America Offers ,000 Guarantee That Stem Cells It Stores Will Engraft in Transplant Procedure Cord Blood America, Inc. , the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced a ,000 Quality Service Guarantee. Read more on PR Newswire via Yahoo! Finance
Human umbilical cord blood cells appear to protect astrocytes from cell death: Research
Human umbilical cord blood cells (HUCB) used to treat cultured rat brain cells (astrocytes) deprived of oxygen appear to protect astrocytes from cell death after stroke-like damage, reports a team of researchers from the University of South Florida (USF) Department of Neurosurgery and Brain Repair. Read more on News-Medical-Net
Adult stem cells succeed for lethal disease
WASHINGTON (BP)–University of Minnesota researchers have used non-embryonic stem cells to treat successfully children with a lethal skin disease. Read more on BPNews.net
Cord Blood America Reports 12% Increase in 2010 Second Quarter Revenue
LAS VEGAS, Aug. 18 /PRNewswire-FirstCall/ — Cord Blood America, Inc. (http://www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, announced today that revenues for the second … Read more on redOrbit
Cord Blood America Reports 12% Increase in 2010 Second Quarter Revenue Cord Blood America, Inc. , the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, announced today that revenues for the second quarter ended June 30, 2010, increased 12 percent to 1,561 compared to 3,950 in the same period in 2009. Read more on PR Newswire via Yahoo! Finance
(out of reviews)
